CRISPR/Cas9
industry news

Manipulating the Fabric of Life

Someone’s famous uncle once said, “With great power comes great responsibility.” Genome editing is an incredibly powerful technique with huge promise and potential for medicine,…

SynBioBeta 2023

 SynBioBeta 2023 With ERS’ Paul Carter  – Sr. Director Business Development & Licensing, North America https://ersgenomics.com/wp-content/uploads/2023/06/Paul-Carter-SynBioBeta-audiogram.mp4 SynBioBeta 2023: Time to scale   The recent SynBioBeta conference…

LSPN Boston 2023: Life Science IP Review

“Although CVC and Broad’s CRISPR/Cas9 gene editing patents currently coexist in the US, pending federal circuit appeal, the picture is clearer in the EPO opposition…

BIO Europe, Basel 2023: Our thoughts

#BIO Europe is one of the most important Life Science events for people in the industry to attend. This year was no exception. ERS Senior Director,…
All articles loaded
No more articles to load